On the development of neoantigen vaccine for HCC cure: from genomics of Hepatitis B Virus (HBV) integration in liver cells to immunological host response toward neoepitopes as novel immunotherapeutic approaches
There is no translation for this page
The information on this page is available in these languages
You may be interested in other contents of Research